Smartkem, which is seeking to change the world of electronics with a new class of transistor technology, have announced that its Board of Directors has authorized management to consider and pursue strategic alternatives involving the Company.
The review will include consideration of transactions intended to increase stockholder value. No timetable has been set for a strategic transaction and there is no assurance that any strategic transaction will result or result in an increase in stockholder value.
The Company reserves the right to terminate its review at any time and may determine not to pursue a strategic transaction. Smartkem intends to continue operating its business in the ordinary course during this process.
While this review is underway, it remains focused on executing its operational plan to unlock the long-term potential and accelerate towards commercialization of its unique and patented technology. Seeking to change the world of electronics with a new class of transistors developed using its proprietary advanced semiconductor materials, Smartkem’s TRUFLEX semiconductor polymers enable low temperature printing processes that are compatible with existing manufacturing infrastructure to deliver low-cost, high-performance displays.
Their semiconductor platform can be used in a range of display technologies including MicroLED, LCD and AMOLED, as well as in applications in advanced computer and AI chip packaging, sensors, and logic. It designs and develops its materials at its research and development facility in Manchester, UK and provides prototyping services at the Centre for Process Innovation (CPI) in Sedgefield, UK.
It operates a field application office in Hsinchu, Taiwan, close to collaboration partner, The Industrial Technology Research Institute (ITRI).
Smartkem is developing a commercial-scale production process and Electronic Design Automation (EDA) tools to demonstrate the commercial viability of manufacturing a new generation of displays using its materials. The company has an extensive IP portfolio including 140 granted patents across 17 patent families, 14 pending patents and 40 codified trade secrets.
